Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Maryland, Baltimore
With
Vanderbilt University
Milton S. Hershey Medical Center
Mercy Medical Center
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of Crohn's disease confirmed by standard criteria
Active luminal Crohn's disease defined by an HBI score of \>4 or with draining perianal Crohn's disease a) Active perianal Crohn's disease defined a presence of draining perianal fistula on physical exam19
Patients with active luminal Crohn's disease must be initiating treatment with an anti-TNF agent (Remicade, Humira, Cimzia, or Simponi) or a steroid (prednisone, Entocort, or Uceris).
Patients with active perianal disease must be initiating therapy with an anti-TNF agent (Remicade, Humira, Cimzia, or Simponi).
Can understand written instructions in English
You may not be if
Previous primary non-response to an anti-TNF
Uncontrolled medical or psychiatric disease (a. Degenerative neurologic condition, b.Unstable angina, c.Class III/IV congestive heart failure, d.Severe asthma or chronic obstructive pulmonary disease, e.Symptomatic peripheral vascular disease, f. Chronic renal insufficiency (creatinine \> 2.0), g. Malignancy within the last 3 years (excluding squamous or basal cell cancers of the skin), h. Poorly controlled depression, mania, and schizophrenia, i. Active infection, j. Acquired immunodeficiency syndrome)
Inability to adhere to the protocol
Need for imminent surgery other than an exam under anesthesia
Under 18 years of age.
Pregnancy
Use of concurrent prednisone \>30 mg per day in the anti-TNF groups
Clareo Health | Impact of Medical Treatment on Sexual Function in Patients With Crohn's Disease
